Scinovex
articleTop 1% cited

Metformin in the treatment of patients with non‐alcoholic steatohepatitis

Alimentary Pharmacology & Therapeutics · 2004 · Vol. 19(5) · pp. 537–544
Ahmet UygunAbdurrahman KadayıfçıA. T. IsikT. OzgurtasS. DeveciAhmet TüzünZeki YeşilovaMustafa GülşenKemal Dağalp

Abstract

The data suggest that improvement of the insulin sensitivity with metformin may improve the liver disease in patients with non-alcoholic steatohepatitis.

Liver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseasePancreatitis Pathology and TreatmentSteatohepatitisMetforminMedicineInsulin resistanceInternal medicineGastroenterologyInsulinFatty liverType 2 diabetesEndocrinology

MeSH terms

AdultBlood GlucoseC-PeptideFemaleHepatitisHumansHypoglycemic AgentsInsulin ResistanceMaleMetforminMiddle AgedTreatment OutcomeSteatorrhea
Citations
406
FWCI
18.03
field-weighted impact
References
24
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Metformin in the treatment of patients with non‐alcoholic steatohepatitis · Scinovex